Weight Loss/Weight Management (Obesity) - Epidemiology Forecast to 2032

January 2022 | 60 pages | ID: W273F62B6935EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Weight Loss/Weight Management (Obesity) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Weight Loss/Weight Management (Obesity) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Weight Loss/Weight Management (Obesity) Understanding

The DelveInsight Weight Loss/Weight Management (Obesity) epidemiology report gives a thorough understanding of the Weight Loss/Weight Management (Obesity) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Weight Loss/Weight Management (Obesity) in the US, Europe, and Japan. The report covers the detailed information of the Weight Loss/Weight Management (Obesity) epidemiology scenario in seven major countries (US, EU5, and Japan).

Weight Loss/Weight Management (Obesity) Epidemiology Perspective by DelveInsight

The Weight Loss/Weight Management (Obesity) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Weight Loss/Weight Management (Obesity) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Weight Loss/Weight Management (Obesity) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Weight Loss/Weight Management (Obesity) Detailed Epidemiology Segmentation

The Weight Loss/Weight Management (Obesity) epidemiology covered in the report provides historical as well as forecasted Weight Loss/Weight Management (Obesity) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Weight Loss/Weight Management (Obesity) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Weight Loss/Weight Management (Obesity) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Weight Loss/Weight Management (Obesity) Epidemiology Report and Model provide an overview of the global trends of Weight Loss/Weight Management (Obesity) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Weight Loss/Weight Management (Obesity) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Weight Loss/Weight Management (Obesity)
• The report provides the segmentation of the Weight Loss/Weight Management (Obesity) epidemiology

Report Highlights

• 11-year Forecast of Weight Loss/Weight Management (Obesity) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Weight Loss/Weight Management (Obesity)
• Cases of Weight Loss/Weight Management (Obesity) by Mutation Types
• Weight Loss/Weight Management (Obesity) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Weight Loss/Weight Management (Obesity)?
• What are the key findings pertaining to the Weight Loss/Weight Management (Obesity) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Weight Loss/Weight Management (Obesity) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Weight Loss/Weight Management (Obesity)?
• What are the currently available treatments of Weight Loss/Weight Management (Obesity)?

Reasons to buy

The Weight Loss/Weight Management (Obesity) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Weight Loss/Weight Management (Obesity) market
• Quantify patient populations in the global Weight Loss/Weight Management (Obesity) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Weight Loss/Weight Management (Obesity) therapeutics in each of the markets covered
• Understand the magnitude of Weight Loss/Weight Management (Obesity) population by its epidemiology
• The Weight Loss/Weight Management (Obesity) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF WEIGHT LOSS/WEIGHT MANAGEMENT (OBESITY)

3. WEIGHT LOSS/WEIGHT MANAGEMENT (OBESITY): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Weight Loss/Weight Management (Obesity) Treatment and Management
6.2. Weight Loss/Weight Management (Obesity) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Weight Loss/Weight Management (Obesity) Epidemiology in 7MM (2019-2032)
Table 2: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Weight Loss/Weight Management (Obesity) Epidemiology in the United States (2019-2032)
Table 4: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Weight Loss/Weight Management (Obesity) Epidemiology in Germany (2019-2032)
Table 6: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Weight Loss/Weight Management (Obesity) Epidemiology in France (2019-2032)
Table 8: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Weight Loss/Weight Management (Obesity) Epidemiology in Italy (2019-2032)
Table 10: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Weight Loss/Weight Management (Obesity) Epidemiology in Spain (2019-2032)
Table 12: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Weight Loss/Weight Management (Obesity) Epidemiology in the United Kingdom (2019-2032)
Table 14: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Weight Loss/Weight Management (Obesity) Epidemiology in Japan (2019-2032)
Table 16: Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Weight Loss/Weight Management (Obesity) Epidemiology in 7MM (2019-2032)
Figure 2 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Weight Loss/Weight Management (Obesity) Epidemiology in the United States (2019-2032)
Figure 4 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Weight Loss/Weight Management (Obesity) Epidemiology in Germany (2019-2032)
Figure 6 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Weight Loss/Weight Management (Obesity) Epidemiology in France (2019-2032)
Figure 8 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Weight Loss/Weight Management (Obesity) Epidemiology in Italy (2019-2032)
Figure 10 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Weight Loss/Weight Management (Obesity) Epidemiology in Spain (2019-2032)
Figure 12 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Weight Loss/Weight Management (Obesity) Epidemiology in the United Kingdom (2019-2032)
Figure 14 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Weight Loss/Weight Management (Obesity) Epidemiology in Japan (2019-2032)
Figure 16 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report